Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy

Clinical trial NCT04554771 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04554771
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Adenocarcinoma Oesophageal Adenocarcinoma Resectable Carcinoma

Start date: 2021-01-27
Primary completion: 2022-10-10
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.